EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology

Kenneth K C Man iD, Anton Pottegård iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Kenneth K C Man und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Databases, Factual, Research Design. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 Research and Innovation Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multi‐national/database pharmacoepidemiological studies are increasingly used to address questions that require pooled evidence across populations but introduce challenges in design, harmonization, and analysis.

Objective

To share 10 practical considerations and common pitfalls in planning, executing, and reporting multi‐national/database studies, with strategies to mitigate them. Approach Practical guidance article synthesizing experience from multi‐national/database projects and literature‐based exemplars; no original data collection.

Results

We summarize ten considerations spanning: protocol development; follow‐up time and eligibility assessment; data harmonization (including thorough metadata and master mapping tables); feasibility checks within each source; statistical model diagnostics; and transparent reporting. We illustrate how local clinical practices, coding systems, and reimbursement policies can shape outcomes and interpretation, and we emphasize the need for proactive, consistent communication among collaborators to ensure aligned implementation.

Conclusion

Multi‐national/database studies are complex but feasible with structured planning, clear communication, and proactive problem‐solving. Adopting the outlined practices can reduce avoidable heterogeneity and improve the robustness and interpretability of findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacoepidemiologyDatabases, FactualResearch DesignHumans

Stichwörter der Autor:innen

common analyticsdata harmonizationmulti‐databasemulti‐national/databasereal‐world data

Autor:innen und Institutionen

  • Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
  • Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Kenneth K C Man, Anton Pottegård

Förderung

  • European Union's Horizon 2020 Research and Innovation Programme

Zitieren

APA

Man, K. K. C., & Pottegård, A. (2025). 10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70203

Vancouver

Man KKC, Pottegård A. 10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70203

BibTeX
@article{Man2025,
  author = {Man, Kenneth K C and Pottegård, Anton},
  title = {10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70203}
}
Kostenlos starten →